Imran Babar, PhD, Chief Business Officer will participate on the Investing Today in Tomorrow’s Life-Transforming Treatments — Opportunities for Venture Capitalists to Move Science to Medicine panel.

For more information:  https://ebdgroup.knect365.com/rare-disease-summit